Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:



Hogan Lovells CES 2023 Recap

In January, sector focused lawyers from Hogan Lovells travelled to Las Vegas to attend CES. Our team enjoyed seeing clients in person as well as seeing the latest products and trends, and...


Hogan Lovells at CES 2023

Lawyers at CES?!


CPRA Countdown: What employers need to know about the CPRA's potential impact on litigation

To date, employee data has been largely exempt from the requirements of the California Consumer Privacy Act of 2018 (CCPA). However, effective January 1, 2023, the Consumer Privacy...


California enforcing broad “stewardship program” requirement for pharmaceutical companies

California’s Pharmaceutical and Sharps Waste Stewardship Act requires pharmaceutical companies doing business in the state to develop and submit a “stewardship plan”...


Building a resilient tech strategy: Cyber attacks

Being an innovative business comes with its challenges and legal risks. In recent years, there has been a major increase in cyber attacks, and this is a real risk for every business. ...


FDA leads global work on continuous manufacturing approaches to up quality, supply chain resilience

Under FDA's leadership, the International Council for Harmonisation (ICH) recently published Q13 draft guidelines on continuous manufacturing (CM) to advance the brand and generic drug...


FDA expands mutual reliance and harmonization with foreign regulators for inspectional oversight

The U.S. Food and Drug Administration’s (FDA) commitment to expand mutual reliance with trusted regulatory partners may be a silver lining for biomedical innovation during an...


FDA issues guidance on conducting remote interactive evaluations during the COVID-19 pandemic

On April 14, the U.S. Food and Drug Administration (FDA) released the immediately-in-effect guidance “Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring...

Media Mention

GP-led Secondaries Report 2021 Private Equity International

In a recent report produced by Private Equity International, Ed Harris and Adam Brown comment on the expanding GP-led secondaries market, including restructurings, continuation funds and...

Loading data